Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Kala Pharmaceuticals
company
Funding Round
Post-IPO Equity
Money Raised
$ 31M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion |
|---|
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 3, 2018 | Post-IPO Equity | $ 110M | Athyrium Capital Management LP | Detail |
| Apr 13, 2016 | Series C | $ 68M | CAM Capital,Longitude Capital,etc. | Detail |
| Feb 28, 2013 | Series A | $ 11.50M | Crown Venture Fund,Lux Capital,etc. | Detail |
| Apr 23, 2014 | Series B | $ 22.50M | AbbVie Biotech Ventures,Crown Venture Fund,etc. | Detail |
| Dec 24, 2009 | Series A | $ 2M | Detail | |
| May 12, 2021 | Post-IPO Debt | $ 125M | Oxford Finance LLC | Detail |
| Mar 14, 2012 | Private Equity（PE） | $ 7.24M | Lighthouse Capital Partners,Lux Capital,etc. | Detail |
| Nov 10, 2010 | Series Unknown | $ 3M | Detail | |
| Apr 6, 2020 | Post-IPO Equity | $ 134M | Detail | |
| Nov 29, 2021 | Post-IPO Equity | $ 16.12M | Detail | |
| Aug 17, 2015 | Series Unknown | $ 6.99M | Detail | |
| Jul 20, 2017 | IPO | $ 90M | Detail |
